Adebrelimab and Concurrent Radiochemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer
Clinical trial NCT06236997 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06236997
- Sponsor
- Henan Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-10
- Primary completion
- 2026-05-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.